Growth Factor Activation BPC-157 has been shown to upregulate growth factor receptors, including those involved in tendon-to-bone healing and soft tissue repair
Phase II data showed 15.6% weight loss at week 32
Higher concentrations (12%) are typically applied in hair restoration protocols
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
In this guide, well examine the different types of GLP-1 medications, how they work in your body, and how to determine if theyre the right choice for you
10.3389/fphys.2015.00397 146
